United Therapeutics Co. (NASDAQ:UTHR) Holdings Boosted by Farallon Capital Management LLC
Farallon Capital Management LLC boosted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 1.4% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 664,767 shares of the biotechnology company’s stock after acquiring an additional 8,894 shares during the period. Farallon […]